We wrote about the risk of diabetes for women in the July issue. Researchers at the University of Massachusetts Medical School in Worchester have studied data on more than 150,000 women in t... Read more
Merck recently announced that it will pay $688 million to settle two class action lawsuits brought by pension funds and other shareholders. The investors accused the company of withholding n... Read more
It’s not too surprising to read that HMG-CoA reductase inhibitors (statins) are taken by millions of people worldwide. The drugs are taken to prevent heart attack, stroke and cardiovascular... Read more
Merck & Co. has settled a patent dispute with Glenmark Pharmaceuticals involving the cholesterol drug Zetia, one of its best-selling products. The lawsuit had been scheduled to go to tri... Read more
There have several lawsuits filed against Merck & Co. and partner Schering-Plough Corp., related to their marketing of cholesterol drug Vytorin. Also, the U.S. Department of Justice is i... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.